Compounds > dexmedetomidine
Page last updated: 2024-08-24

dexmedetomidine and HbS Disease

dexmedetomidine has been researched along with HbS Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afsar, N; Almeida, LE; Calhoun, G; Finkel, JC; Kenyon, N; Nouraie, M; Quezado, ZM; Wang, L1
Darbari, DS; Finkel, JC; Guerrera, MF; Quezado, ZM; Sheehy, KA1
Dickey, S; Gadiraju, S; Galli, R; Lerant, AA; Phillips, WJ1

Other Studies

3 other study(ies) available for dexmedetomidine and HbS Disease

ArticleYear
Dexmedetomidine ameliorates nocifensive behavior in humanized sickle cell mice.
    European journal of pharmacology, 2015, May-05, Volume: 754

    Topics: Adrenergic alpha-2 Receptor Agonists; Anemia, Sickle Cell; Animals; Dexmedetomidine; Dose-Response Relationship, Drug; Female; Hand Strength; Humans; Hypnotics and Sedatives; Mice; Mice, Transgenic; Pain; Pain Measurement; Vocalization, Animal; Wakefulness

2015
Dexmedetomidine as an Adjuvant to Analgesic Strategy During Vaso-Occlusive Episodes in Adolescents with Sickle-Cell Disease.
    Pain practice : the official journal of World Institute of Pain, 2015, Volume: 15, Issue:8

    Topics: Adolescent; Analgesics, Non-Narcotic; Anemia, Sickle Cell; Dexmedetomidine; Female; Humans; Infusions, Intravenous; Male; Pain; Pain Management; Pain Measurement

2015
Dexmedetomidine relieves pain associated with acute sickle cell crisis.
    Journal of pain and symptom management, 2007, Volume: 34, Issue:4

    Topics: Adult; Analgesics, Non-Narcotic; Anemia, Sickle Cell; Dexmedetomidine; Female; Humans; Male; Pain; Pain Measurement; Treatment Outcome

2007